240 related articles for article (PubMed ID: 38058996)
1. Developmental outcomes with perinatal exposure (DOPE) to prescription opioids.
Flores A; Nguyen NM; Pendyala G
NeuroImmune Pharm Ther; 2023 Dec; 2(4):339-351. PubMed ID: 38058996
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
[TBL] [Abstract][Full Text] [Related]
3. Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry.
Grecco GG; Mork BE; Huang JY; Metzger CE; Haggerty DL; Reeves KC; Gao Y; Hoffman H; Katner SN; Masters AR; Morris CW; Newell EA; Engleman EA; Baucum AJ; Kim J; Yamamoto BK; Allen MR; Wu YC; Lu HC; Sheets PL; Atwood BK
Elife; 2021 Mar; 10():. PubMed ID: 33724184
[TBL] [Abstract][Full Text] [Related]
4. Potential problems and solutions of opioid-based treatment in neonatal opioid withdrawal syndrome (NOWS): a scoping review protocol.
Mills-Huffnagle S; Nyland JE
BMJ Open; 2023 Feb; 13(2):e067883. PubMed ID: 36806065
[TBL] [Abstract][Full Text] [Related]
5. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018.
Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB
Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554
[No Abstract] [Full Text] [Related]
6. Maternal and iatrogenic neonatal opioid withdrawal syndrome: Differences and similarities in recognition, management, and consequences.
Isaac L; van den Hoogen NJ; Habib S; Trang T
J Neurosci Res; 2022 Jan; 100(1):373-395. PubMed ID: 33675100
[TBL] [Abstract][Full Text] [Related]
7. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
Baldo BA
Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
[TBL] [Abstract][Full Text] [Related]
8. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
[TBL] [Abstract][Full Text] [Related]
9. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS.
Velez ML; Jordan C; Jansson LM
Neurotoxicol Teratol; 2021; 88():107032. PubMed ID: 34600100
[TBL] [Abstract][Full Text] [Related]
10. Perinatal oxycodone exposure causes long-term sex-dependent changes in weight trajectory and sensory processing in adult mice.
Minakova E; Mikati MO; Madasu MK; Conway SM; Baldwin JW; Swift RG; McCullough KB; Dougherty JD; Maloney SE; Al-Hasani R
Psychopharmacology (Berl); 2022 Dec; 239(12):3859-3873. PubMed ID: 36269379
[TBL] [Abstract][Full Text] [Related]
11. Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndrome.
Radhakrishna U; Vishweswaraiah S; Uppala LV; Szymanska M; Macknis J; Kumar S; Saleem-Rasheed F; Aydas B; Forray A; Muvvala SB; Mishra NK; Guda C; Carey DJ; Metpally RP; Crist RC; Berrettini WH; Bahado-Singh RO
Genomics; 2021 May; 113(3):1127-1135. PubMed ID: 33711455
[TBL] [Abstract][Full Text] [Related]
12. Clinical care of neonates undergoing opioid withdrawal in the immediate postpartum period.
Oji-Mmuo CN; Jones AN; Wu EY; Speer RR; Palmer T
Neurotoxicol Teratol; 2021; 86():106978. PubMed ID: 33838247
[TBL] [Abstract][Full Text] [Related]
13. Opioid Use in Pregnancy.
Tobon AL; Habecker E; Forray A
Curr Psychiatry Rep; 2019 Nov; 21(12):118. PubMed ID: 31734808
[TBL] [Abstract][Full Text] [Related]
14. Decreased myelin-related gene expression in the nucleus accumbens during spontaneous neonatal opioid withdrawal in the absence of long-term behavioral effects in adult outbred CFW mice.
Borrelli KN; Wingfield KK; Yao EJ; Zamorano CA; Sena KD; Beierle JA; Roos MA; Zhang H; Wachman EM; Bryant CD
Neuropharmacology; 2023 Dec; 240():109732. PubMed ID: 37774943
[TBL] [Abstract][Full Text] [Related]
15. Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant.
Wouldes TA; Lester BM
Front Pediatr; 2023; 11():1305508. PubMed ID: 38250592
[TBL] [Abstract][Full Text] [Related]
16. Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure.
Morris E; Bardsley T; Schulte K; Seidel J; Shakib JH; Buchi KF; Fung CM
Am J Perinatol; 2022 Mar; 39(4):387-393. PubMed ID: 32892326
[TBL] [Abstract][Full Text] [Related]
17. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
[TBL] [Abstract][Full Text] [Related]
18. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
[TBL] [Abstract][Full Text] [Related]
19. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA
J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
